ArticleChina CDC weekly2022
Application of Disability-Adjusted Life Years to Evaluate the Burden and Trend of Tuberculosis - China, 1990-2019.
Article in China CDC weekly, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Evaluation of pulmonary tuberculosis disease burden in Shenyang, China, 2023.BMC infectious diseases · 2025Article
- Temporal trends in disability adjusted life year and mortality for colorectal cancer attributable to a high red meat diet in China from 1990 to 2021: an analysis of the global burden of disease study 2021.BMC gastroenterology · 2024Article
- Burdens Attributable to Intimate Partner Violence in Women Aged 15 Years or Older - China, 1990-2019.China CDC weekly · 2023Article
- Temporal trends in mortality of tuberculosis attributable to high fasting plasma glucose in China from 1990 to 2019: a joinpoint regression and age-period-cohort analysis.Frontiers in public health · 2023Article
- Clinical significance of CA-125 in elderly patients with active pulmonary tuberculosis: A retrospective study.Saudi medical journal · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
What is already known about this topic?: China is a country with a high burden of tuberculosis (TB). However, the evaluation of TB burden is usually based on traditional epidemiological indicators, and disability-adjusted life year (DALY) is rarely applied. What is added by this report?: In China, the number of DALYs caused by TB in 2019 was estimated to be 1.36 million, and the age-standardized rate (ASR) was 86.46/100,000. The DALYs of TB decreased significantly from 1990 to 2019, with the largest decline from 2001 to 2010. The burden is higher among men than women, and the highest among the elderly. What are the implications for public health practice?: Application of DALYs can reflect the damage in health to China's residents caused by tuberculosis. In the future, we should strengthen research, monitor years lived with disability (YLDs), and reduce the burden of the elderly and men. Cost-effective analysis based on DALYs should be conducted to provide a scientific basis for decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.